Overview

Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
A randomized, open label, dose titration study to evaluate the efficacy and safety of Pitavastatin compared to atorvastatin in Type 2 Diabetes Mellitus with hypercholesterolemia
Phase:
Phase 4
Details
Lead Sponsor:
JW Pharmaceutical
Treatments:
Atorvastatin
Atorvastatin Calcium
Pitavastatin